Status:
RECRUITING
Patient Derived Preclinical Models
Lead Sponsor:
Mayo Clinic
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Study goal is to collect tumor specimens that may inform cancer biology to eventually improve outcomes for patients with cancer. This proposal represents a highly collaborative effort to support cance...
Detailed Description
The objective of this study is to collect tumor specimens (tumor tissues, matched normal tissue when possible, and 50 mL of blood) that may inform cancer biology to eventually improve outcomes for pat...
Eligibility Criteria
Inclusion
- 18 years of age and older
- Patient is a good medical candidate for a standard of care or research biopsy or surgical procedure to obtain tissue
Exclusion
- Uncontrolled concurrent illness including psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly give written informed consent
- Institutionalized or incarcerated patients
- Inaccessible tumor for biopsy or patient does not have tumor tissue available for research use
- Biopsy must not be considered more than minimal risk to the patient.
- Have a contraindication to percutaneous biopsy including:
- Significant coagulopathy that cannot be adequately corrected.
- Severely compromised cardiopulmonary function or hemodynamic instability.
- Lack of a safe pathway to the lesion per the interventional radiologist.
- Inability of the patient to cooperate with, or to be positioned for, the procedure.
Key Trial Info
Start Date :
April 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05324553
Start Date
April 6 2022
End Date
March 31 2028
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905